未登录

G

Gabriel Bastien

université de montréal

H指数:6

被引数:100

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Sex-based effectiveness in buprenorphine/naloxone and methadone treatment for opioid use disorder: findings from the OPTIMA trial

性别差异在丁丙诺啡/纳洛酮和美沙酮治疗阿片类药物使用障碍中的效果：OPTIMA试验的结果

Drug and Alcohol Dependence

IF3.6

2026-05-070

OAAI

Concordance Between Urine Drug Screening and Self-Reported Use in the Context of a Pragmatic Randomized-Controlled Trial in People with Prescription-Type Opioid Use Disorder: Concordance entre le dépistage de drogues dans l’urine et l’usage autodéclaré dans le contexte d’un essai pragmatique contrôlé à répartition aléatoire chez des personnes présentant un trouble lié à l'usage d’opioïdes vendus sur ordonnance

尿液药物筛查与自报使用的一致性：一项在处方型阿片类药物使用障碍人群中进行的实用性随机对照试验中的结果（法语：尿液药物筛查与自报使用的一致性：一项在处方型阿片类药物使用障碍人群中进行的实用性随机对照试验中的结果）

The Canadian Journal of Psychiatry

IF0

2025-08-280

OAAI

Opioid consumption frequency and its associations with potential life problems during opioid agonist treatment in individuals with prescription-type opioid use disorder: exploratory results from the OPTIMA Study

HARM REDUCTION JOURNAL

IF4

2025-02-080

OAAI

Efficacy and Safety of Modafinil for Treatment of Amphetamine-Type Stimulant Use Disorder: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials

DRUG AND ALCOHOL DEPENDENCE

IF3.6

2025-02-010

PRE

Development and Validation of a Hepatitis C Risky Injection Behaviours Index in a Cohort of People who Inject Drugs Located in Montreal, Canada

DRUG AND ALCOHOL DEPENDENCE

IF3.6

2025-02-010

PRE

Efficacy and Safety of Modafinil for Treatment of Amphetamine-Type Stimulant Use Disorder: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials: Efficacité et innocuité du modafinil pour le traitement des troubles liés à l'usage de stimulants de type amphétamine : revue systématique et méta-analyse d'essais randomisés contrôlés par placebo

CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE

IF3.8

2024-07-210

PRE

Mediating effect of craving on the impact of buprenorphine/naloxone and methadone treatment on opioid use: Results from a randomized controlled trial

ADDICTIVE BEHAVIORS

IF3.6

2024-07-012

PRE

The Association Between Self-Reported Anxiety and Retention in Opioid Agonist Therapy: Findings From a Canadian Pragmatic Trial

CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE

IF3.8

2023-09-122

OAAI

Effects of Buprenorphine/Naloxone and Methadone on Depressive Symptoms in People with Prescription Opioid Use Disorder: A Pragmatic Randomised Controlled Trial

CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE

IF3.8

2022-12-148

OAAI

Variations of cannabis-related adverse mental health and addiction outcomes across adolescence and adulthood: A scoping review

FRONTIERS IN PSYCHIATRY

IF3.2

2022-10-107

OAAI

Buprenorphine/naloxone and methadone effectiveness for reducing craving in individuals with prescription opioid use disorder: Exploratory results from an open-label, pragmatic randomized controlled trial

DRUG AND ALCOHOL DEPENDENCE

IF3.6

2022-10-017

OAAI

Preferences for research design and treatment of comorbid depression among patients with an opioid use disorder: A cross-sectional discrete choice experiment

DRUG AND ALCOHOL DEPENDENCE

IF3.6

2021-09-014

OAAI

A systematic review of technology-based psychotherapeutic interventions for decreasing cannabis use in patients with psychosis

PSYCHIATRY RESEARCH

IF3.9

2020-06-0114

OAAI